ANEB
Anebulo Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.00
+75.00%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-100.5%
Return on equity
-84.7%
Return on assets
-114.7%
Return on invested capital
0.00x
Asset turnover
-$5.8M
Cash from operations
$0.22
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025